US drug and medical supplies distributor Cardinal Health has simultaneously acquired urology-focused medical supplier Strive Medical and AdaptHealth’s diabetes business in a deal duo totalling $360m that is positioned to advance its home care business service provision.
Regarding diabetes, the buyout of AdaptHealth’s business unit follows Cardinal’s buyout of Advanced Diabetes Supply (ADS) in April 2025.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Meanwhile, the acquisition of Strive Medical follows Cardinal’s recent moves to advance its urology provision, with the $1.9bn buyout of Solaris Health in August 2025, Academic Urology & Urogynecology in the same month, and buyouts of Urology America and Potomac Urology in April 2025.
The latest acquisition duo is intended to support the advancement of Cardinal’s at-home solutions business while expanding its ability to “deliver high-quality service at scale”, the company stated.
“These strategic transactions build on the synergies created by our recent investments in home care,” said Cardinal CEO Jason Hollar.
“As a natural extension of our at-home solutions growth strategy, they expand our enterprise-wide depth and breadth across important therapeutic categories like diabetes management and urology, further strengthening our leadership in a highly dynamic industry,” Hollar continued.
Cardinal’s at-home solutions business provides medical supplies direct to patients and supports ‘hospital-at-home’ programmes across the US. The Ohio-based company highlighted that its acquisition of ADS has already had an appreciable impact on its at-home business’s operations, with the acquisitions of Strive and AdaptHealth’s diabetes business anticipated to further this momentum.
Since closing the original ADS transaction, Cardinal highlighted that its team has migrated all ADS volume onto the at-home solutions business’s distribution network, onboarded nearly 500,000 new customers, and launched ContinuCare Pathway, a pharmacy-to-supplier digital referral pathway programme.
Cardinal’s at-home solutions business president, Rob Schlissberg, commented: “Our significant operational achievements in FY26 position us to continue building the country’s leading platform to deliver simplified, innovative and high-quality care in the home, both organically and through acquisition.”
